The ransomware claim alleges that the threat actor incransom targeted continuumindia.com, a US-based contract research organization specializing in drug safety monitoring and regulatory services for the pharmaceutical industry. The attack potentially jeopardizes sensitive client data and operational integrity, impacting healthcare industry stakeholders in the US. #US
Incident Details
- Victim: continuumindia.com
- Country: US
- Actor: incransom
- Source: http://incblog6qu4y4mm4zvw5nrmue6qbwtgjsxpw6b7ixzssu36tsajldoad.onion/blog/disclosures/691cbfb3e1a4e4b3ff530e17
- Discovered: 2025-11-18 19:24:18.251588
- Published: 2025-11-18 16:04:00.000000
Information
- Continuum India is a contract research organization specializing in drug safety monitoring and regulatory services for the pharmaceutical industry.
- They offer services such as pharmacovigilance, evidence evaluation, and technology solutions to improve patient safety and ensure regulatory compliance.
- The company’s target clients are globally recognized healthcare brands, providing integrated, high-performance services across various therapeutic areas.
- Continuum India is committed to excellence and utilizes advanced technologies, including automation, to deliver accurate and timely results.
- The organization has 250 employees and generates an annual revenue of $14 million.
- Although their industry is listed as retail, their core focus is on pharmaceutical services.
- Their contact phone number is (203) 274-0016.
Disclaimer: This post is based on public claims made by the ransomware group "incransom". I cannot confirm the accuracy of the information. However, I would be happy to share any official statement from the affected organization to provide clarification.